Business Description
BeiGene Ltd
NAICS : 325412
ISIN : US07725L1026
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.38 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | -1.38 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.86 | |||||
Beneish M-Score | -1.97 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 85.3 | |||||
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 24.3 | |||||
3-Year FCF Growth Rate | 2.4 | |||||
3-Year Book Growth Rate | -7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.81 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -25.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.98 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 1.34 | |||||
Days Inventory | 305.21 | |||||
Days Sales Outstanding | 45.53 | |||||
Days Payable | 253.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -1.16 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.98 | |||||
Operating Margin % | -28.62 | |||||
Net Margin % | -16.91 | |||||
FCF Margin % | -43.27 | |||||
ROE % | -14.69 | |||||
ROA % | -9.21 | |||||
ROIC % | -39.17 | |||||
3-Year ROIIC % | 27.56 | |||||
ROC (Joel Greenblatt) % | -61.5 | |||||
ROCE % | -22.02 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.41 | |||||
PB Ratio | 6.87 | |||||
Price-to-Tangible-Book | 6.98 | |||||
EV-to-EBIT | -25.81 | |||||
EV-to-Forward-EBIT | -11.26 | |||||
EV-to-EBITDA | -28.93 | |||||
EV-to-Forward-EBITDA | -11.92 | |||||
EV-to-Revenue | 7.39 | |||||
EV-to-Forward-Revenue | 4.32 | |||||
EV-to-FCF | -16.87 | |||||
Price-to-Net-Current-Asset-Value | 15.48 | |||||
Price-to-Net-Cash | 93.74 | |||||
Earnings Yield (Greenblatt) % | -3.87 | |||||
FCF Yield % | -5.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BeiGene Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 53,939.549 | ||
EPS (TTM) (MXN) | -89.306 | ||
Beta | 0.37 | ||
Volatility % | 25.95 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0.000115 | ||
20-Day SMA (MXN) | 2858.16 | ||
12-1 Month Momentum % | -25.95 | ||
52-Week Range (MXN) | 2858.16 - 3860 | ||
Shares Outstanding (Mil) | 106.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BeiGene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BeiGene Ltd Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
BeiGene Ltd Frequently Asked Questions
What is BeiGene Ltd(MEX:BGNE)'s stock price today?
When is next earnings date of BeiGene Ltd(MEX:BGNE)?
Does BeiGene Ltd(MEX:BGNE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |